These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3258889)

  • 1. Sensitization and desensitization to lethal effects of tumor necrosis factor and IL-1.
    Wallach D; Holtmann H; Engelmann H; Nophar Y
    J Immunol; 1988 May; 140(9):2994-9. PubMed ID: 3258889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The glucocorticoid antagonist RU38486 mimics interleukin-1 in its sensitization to the lethal and interleukin-6-inducing properties of tumor necrosis factor.
    Brouckaert P; Everaerdt B; Fiers W
    Eur J Immunol; 1992 Apr; 22(4):981-6. PubMed ID: 1532365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of the liver, but not of IL-6, in IL-1-induced desensitization to the lethal effects of tumor necrosis factor.
    Libert C; Van Bladel S; Brouckaert P; Shaw A; Fiers W
    J Immunol; 1991 Apr; 146(8):2625-32. PubMed ID: 1849935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does high mobility group 1 protein function as a late mediator for LPS- or TNF-induced shock in galactosamine-sensitized mice?
    Hasunuma R; Maruyama H; Takimoto H; Ryll R; Tanaka S; Kumazawa Y
    J Endotoxin Res; 2002; 8(5):391-8. PubMed ID: 12537698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of interleukin-6-deficient mice to tumor necrosis factor-induced metabolic changes and lethality.
    Libert C; Takahashi N; Cauwels A; Brouckaert P; Bluethmann H; Fiers W
    Eur J Immunol; 1994 Sep; 24(9):2237-42. PubMed ID: 7522168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etoposide prevents apoptosis in mouse liver with D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure resulting in reduction of lethality.
    Nakama T; Hirono S; Moriuchi A; Hasuike S; Nagata K; Hori T; Ido A; Hayashi K; Tsubouchi H
    Hepatology; 2001 Jun; 33(6):1441-50. PubMed ID: 11391533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection, characterisation and purification of a murine liver factor capable of desensitising towards the lethal activity of tumour necrosis factor.
    Wielockx B; Hochepied T; Staelens J; Van Molle W; Brouckaert P; Libert C
    Cytokine; 2001 Jul; 15(2):59-65. PubMed ID: 11500080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of STAT1/IRF-1 on synergistic ROS production and loss of mitochondrial transmembrane potential during hepatic cell death induced by LPS/d-GalN.
    Lee HJ; Oh YK; Rhee M; Lim JY; Hwang JY; Park YS; Kwon Y; Choi KH; Jo I; Park SI; Gao B; Kim WH
    J Mol Biol; 2007 Jun; 369(4):967-84. PubMed ID: 17475277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytosine-phosphate-guanine (CpG) motifs are sensitizing agents for lipopolysaccharide in toxic shock model.
    Cornélie S; Wiel E; Lund N; Lebuffe G; Vendeville C; Riveau G; Vallet B; Ban E
    Intensive Care Med; 2002 Sep; 28(9):1340-7. PubMed ID: 12209287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
    Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ
    J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential response of a(2)-macroglobulin-deficient mice in models of lethal TNF-induced inflammation.
    Hochepied T; Ameloot P; Brouckaert P; Van Leuven F; Libert C
    Eur Cytokine Netw; 2000 Dec; 11(4):597-601. PubMed ID: 11125302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of antimicrobial peptides derived from the beetle Allomyrina dichotoma defensin on endotoxic shock in mice.
    Koyama Y; Motobu M; Hikosaka K; Yamada M; Nakamura K; Saido-Sakanaka H; Asaoka A; Yamakawa M; Sekikawa K; Kitani H; Shimura K; Nakai Y; Hirota Y
    Int Immunopharmacol; 2006 Feb; 6(2):234-40. PubMed ID: 16399628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant IL-1 receptor antagonist protects against TNF-induced lethality in mice.
    Everaerdt B; Brouckaert P; Fiers W
    J Immunol; 1994 May; 152(10):5041-9. PubMed ID: 8176222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-alpha production and protect mice against endotoxin challenge.
    Parmely MJ; Zhou WW; Edwards CK; Borcherding DR; Silverstein R; Morrison DC
    J Immunol; 1993 Jul; 151(1):389-96. PubMed ID: 8326132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with Y-40138, a multiple cytokine production modulator, inhibits lipopolysaccharide- or tumour necrosis factor-alpha-induced production of pro-inflammatory cytokines and augments interleukin-10.
    Fukuda T; Hisadome M; Komatsu H
    J Pharm Pharmacol; 2005 Nov; 57(11):1461-6. PubMed ID: 16259779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low susceptibility of NC/Nga mice to tumor necrosis factor-alpha-mediated lethality and hepatocellular damage with D-galactosamine sensitization.
    Koide N; Morikawa A; Naiki Y; Tumurkhuu G; Yoshida T; Ikeda H; Yokochi T
    Clin Immunol; 2009 Feb; 130(2):225-32. PubMed ID: 18945641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of interleukin-10 at the time of priming protects Corynebacterium parvum-primed mice against LPS- and TNF-alpha-induced lethality.
    Smith SR; Terminelli C; Denhardt G; Narula S; Thorbecke GJ
    Cell Immunol; 1996 Nov; 173(2):207-14. PubMed ID: 8912878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement by galactosamine of lipopolysaccharide(LPS)-induced tumour necrosis factor production and lethality: its suppression by LPS pretreatment.
    Endo Y; Shibazaki M; Yamaguchi K; Kai K; Sugawara S; Takada H; Kikuchi H; Kumagai K
    Br J Pharmacol; 1999 Sep; 128(1):5-12. PubMed ID: 10498828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schedule-dependent enhanced lethality with combined administration of actinomycin D and tumor necrosis factor in mice.
    Buckley NJ; Walther PJ; Das AK; Poulton SH
    J Biol Response Mod; 1989 Jun; 8(3):287-96. PubMed ID: 2746299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-activating factor is a mediator in tumor necrosis factor/galactosamine-induced lethality.
    Libert C; Van Molle W; Brouckaert P; Fiers W
    J Inflamm; 1995-1996; 46(3):139-43. PubMed ID: 8844494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.